Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
  • A61N1/00—Electrotherapy; Circuits therefor
  • A61N1/14—Leading-off electric charges, e.g. by earthing
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K38/00—Medicinal preparations containing peptides
  • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
  • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
  • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
  • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
  • A61N1/00—Electrotherapy; Circuits therefor
  • A61N1/16—Screening or neutralising undesirable influences from or using, atmospheric or terrestrial radiation or fields
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
  • A61N1/00—Electrotherapy; Circuits therefor
  • A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
  • A61N2/00—Magnetotherapy
  • A61N2/02—Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets

Definitions

• the inventions are directed to methods and electrical, electronic, and electromagnetic devices, systems and installations and their
• ionizing radiation such as ultraviolet light, gamma rays or beta rays
• atherosclerosis
• the inventions involve applying certain electric, magnetic or
• a number of changes within cells are produced by ischemia, hypoxia, or
• HSPs heat shock proteins
• HSP70i HSP72
• HSP70 I mean the inducible form. Although first discovered following an elevation
• HSPs proteins
• the HSPs help the cell survive by assisting damaged cells with repair and protecting
• HSPs ensure that
• Cross protection or “cross tolerance” are terms which describes the use of a non-lethal application of one
• stress e.g. heat
• another stress e.g. heat
• heat shock confers resistance to the cell against a subsequent, normally lethal
• Cardiomyocytes respond to hypoxia and metabolic stress with increased HSP70
• hypotonicity or simulated ischemia, these cells were better able to survive than the
• heat shock (or stress) proteins such as HSP70, HSP90, HSP60 and HSP27. Some of these have been implicated in the development
• the second method would employ a pharmocologic approach by developing drugs that induce the endogenous HSP gene.
• HSP70 a 70 kD polypeptide
• HSP70 is either reduced by EM fields or only a negligible (2%) increase occurs under
• the method utilizes a
• the wave forms of the current in the coils must contain a DC component.
• Jacobson proposes that patients must be exposed over extended
• the method describes a method of combating mortality in a cell or tissue under stress. The method
• HSP70 comprises contacting HSP70 to the cell or tissue in an amount effective to enhance the
• the method may be employed in the combating of
• a pharmaceutical composition comprising a
• an ischemic event e.g., angina attack
• angina attack e.g., angina attack
• the methods comprise inducing heat shock proteins by applying a
• the method comprises inducing heat shock
• the tissue may
• Fig. 1 shows the effect of changing the rms amplitude of a 60 Hz magnetic
• Fig. 2 shows field generating coils on opposite sides of a hat worn by a
• Fig. 3 shows field generating coils on the front and rear of a vest worn by a
• Fig. 4 shows an alternative form of vest, secured by Velcro straps.
• Fig. 5 shows a single field generating coil within a pillow or pad.
• Fig. 6a shows a front view of body clothing with a field generating coil there
• Fig. 6b shows a coil as in Figure 5 but on the back of the clothing.
• this exposure can be started up to two or more hours in advance of the ischemic event
• its magnitude preferably be should be in the range 4 to 10 ⁇ T. Below 4 ⁇ T the
• condition on amplitude is that it preferably be above 4 ⁇ T everywhere in the tissue to
• Fields as high as 100 ⁇ T or more are effective.
• Non-sinusoidal wave forms can be used but they offer no advantage.
• the preferable pulse repetition rates for pulses are above 30 Hz. If an electric field is directly applied, the preferable range of frequencies is 15 to 100 Hz.
• frequency of the field is in the range 15 to 100 Hz. For frequencies higher than this
• radio frequency (RF) or microwave is
• Pulse modulated waves are not as
• the exposure time is of the order of 20 minutes or longer, during this exposure
• time the field parameters may vary but should
• amplitude should not vary by more than about 10% during any 10 second time period.
• 50 or 60 Hz sinusoids is quite trivial when the power frequency is 50 or 60 Hz (e.g. in
• the magnetic fields should preferably be about 1000 times smaller than that taught by Markoll. I have also discovered that a single short time
• Cells of any origin may be treated by the methods of the present invention.
• Cells including animal, plant, and bacterial cells. Cells may be treated in vitro or in vivo.
• tissues of any origin including animal and plant tissue, may be treated by
• tissues are preferred for carrying out the present inventions, with mammalian (e.g.,
• veterinary medicine such as dog, cat, cow, pig, and
• Cells and tissue which are under stress are treated with a magnetic field to combat mortality.
• cells which are maintained in culture e.g., for the
• organs could be placed in a sinusoidal time varying
• Tissue under stress in vivo may also be treated by electromagnetically
• HSP70 inducing HSP70 and other stress proteins.
• arterial and myocardial tissue for example, arterial and myocardial tissue
• Cardiac ischemia may be treated by
• the kidney may be any kidney that infarction to enhance the survivability of cells in those tissues.
• the kidney may be any kidney that infarction to enhance the survivability of cells in those tissues.
• the kidney may be any kidney
• Arterial tissue may be protected during laser
• Nerve tissue i.e., peripheral nerve tissue
• nerve and central nerve which is under stress in vivo may also be treated by the
• peripheral nerves which are severed are peripheral nerves which are severed.
• nerve cell or soma, if too great a portion of the nerve's axon is distal to the site of the
• HSPs to maximize production of HSPs may be applied to such nerve tissue to combat cell
• Nerve tissue may also be subject to anoxic stress in vivo.
• anoxic stress for example, anoxic
• the damaged supply vessel is most severely damaged; tissue furthest from the
• the present inventions may be employed to combat restenosis
• Angioplasty is a procedure for dilating arteries which are occluded
• a catheter which carries an inflatable dilation balloon at the distal end is employed to reshape a partially occluded artery.
• the balloon is inserted in the deflated condition in the restricted
• the obstructing material is neither
• the dilation balloon is deflated and removed. The site of the
• formed obstruction may, however, become reoccluded when/if the vessel returns to its
• after angioplasty prior to the onset of restenosis may be treated by applying a time- varying magnetic field to the lumen of the vessel which has been reshaped.
• ionizing radiation e.g. UV light, x-rays, or gamma rays
• Skin tissue under stress due to ultra violet irradiation may be
• tumor cells can be destroyed without causing as
• a magnetic field can be used after exposure to UV to enhance repair and healing of the tissue.
• the magnetic field can also be applied before exposure to,
• Tissues may also be under stress due to chemotherapeutic treatment, as in
• the magnetic field can be applied prior to or after the
• chemotherapeutic treatment as both a protective and healing agent.
• tissue temperature is applied within 30 minutes to several hours later. For example following a 20 minute exposure to a 4 ⁇ T 60 Hz field the tissue temperature needs to be raised to
• Examples of this are a focused ultrasonic beam or a magnetic resonance imaging
• the probability of a successful graft is greatly increased if, before removing the
• the magnetic field may be applied either concurrently or in combination with other therapeutic agents.
• the field may be combined with another agent
• agents include anti-oxidants or anti-oxidants.
• free radical scavengers such as vitamins C and E and superoxide dismutase when the damaging event works through the production of reactive oxygen molecules.
• indomethacin which are known 21 to sensitize the cell to respond to stimuli known to
• the other agent might be one which reduces the influx of excess
• calcium ions e.g., in brain tissue
• tissue plasminogen removes the blockage of blood flow to the heart muscle, such as tissue plasminogen
• TPA streptokinase
• Flasks were removed from the incubator (this occurring at 5.5 h following
• HBSS balanced salt solution
• Control cells remained in their original medium.
• HBSS contains the following; 1.3 mM CaCl 2 , 5.0 mM KC1, 0.3 mM KH 2 PO 4 ,
• Dishes were placed in a CO 2 -injection, cell culture incubator and
• time varying magnetic field can confer protection against anoxia in biological cells.
• n the number of different runs for a given exposure condition.
• n the number of embryos for a given exposure condition.
• a periodic signal generator operating in the range of 10 to 30,000 Hz, and a
• Both the signal generator and the coil can be any signal generator and the coil.
• Example 1 AC powered, transformer coupled, power frequency generator
• the protective signal generator can be implemented as a simple voltage transformer.
• the transformer could be designed with a secondary
• a generator of this type would be very economical, consisting solely of
• Example 2 ac powered, transformer coupled, periodic signal generator
• An ac source can also be used to implement the protection signal generator as
• the signal generator would generally consist of a dc source, a circuit to make the ELF
• suitable periodic signals include sinusoidal waves, triangular
• Sinusoidal, triangular, and square wave generators can be designed
• any type of signal can be generated with a microprocessor or a microcontroller and the appropriate software control. While the
• transistor current amplifier could be used when the periodic signal is a pulsing dc
• Suitable audio power amplifiers can be made using discrete
• Example 3 Battery driven periodic signal generator
• the signal generator can be easily
• the generator would consist of a
• circuit to make the periodic signal of choice and a circuit to couple the periodic
• Such a device could be made into a unit that could, for instance, be worn on a belt, attached to a pocket, or hung on a chain around the
• Attachment to the coil would be via a physical paired wire connection.
• the EMF generating coil should consists of one or more multi-turn
• coils of conducting material for instance wire, arranged and connected in such a
• the coils can be any electromagnetic fields prescribed in the present invention.
• the coils can be any electromagnetic fields prescribed in the present invention.
• the coils can be any electromagnetic fields prescribed in the present invention.
• the coils can be any electromagnetic fields prescribed in the present invention.
• the coils can be any electromagnetic fields prescribed in the present invention.
• the coils can be any electromagnetic fields prescribed in the present invention.
• the coils can be any electromagnetic fields prescribed in the present invention.
• the coils can be any electromagnetic fields prescribed in the present invention.
• Example 1 Dual coil configuration
• This type of dual coil called a Helmholtz coil, can allow
• the coils could be located on opposite sides of a hat worn by the patient.
• Figure 2 reference character 1 points to a cap to be worn on the head of a human
• a multiturn coil 2 of electrically conductive wire is placed on one side of the
• coils could be on the front and rear, or on any other desired axis across the cap. If the target is the heart, the coils could be located on the front and back sides of a vest which can be slipped over the head of patient and secured to his/her torso with side
• a vest 4 is illustrated to be worn over the chest and back of a
• an opening 5 being provided for slipping down over the patient's head.
• Helmholtz coils 2 and 3 are shown on the front and rear panels of the vest.
• the coils could be installed side by side, with suitable distance in
• the band could be
• FIG 4 shows another form of vest 6 which is wrapped around the patient's torso
• the coil can be placed within a pillow or pad.
• Figure 5 shows a single coil 9 placed in a pillow or pad 10 on which the patient's
• head may rest while asleep, of dimensions such that when a patient rest his/her head
• the head region is subjected to the appropriate field which can cause the desired
• One example of a single coil embodiment consists a multi-turn
• volume varies within ⁇ 45% of the average of the maximum and minimum fields.
• the specified volume would be between approximately 4 mG and 13 mG.
• Either single, dual or other multi coil applicators can be designed as part of
• FIG. 6a a body suit or garment is shown on which a coil 11 is in
• Figure 6b shows a second coil 12
• the coils may be placed at any elevation on any axis across the
• Either the dual coil band applicator or the single coil applicator can be any combination of the dual coil band applicator or the single coil applicator.
• a device with built-in monitoring to detect threatening conditions could be designed for high risk patients. This device would be worn at all times and would be
• protection signal generator could be achieved via a wireless link using
• inducible stress protein in rat heart myogenic cells confers protection against

Landscapes

• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Engineering & Computer Science (AREA)
• Animal Behavior & Ethology (AREA)
• General Health & Medical Sciences (AREA)
• Public Health (AREA)
• Veterinary Medicine (AREA)
• Biomedical Technology (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Radiology & Medical Imaging (AREA)
• Marine Sciences & Fisheries (AREA)
• Zoology (AREA)
• Gastroenterology & Hepatology (AREA)
• Chemical & Material Sciences (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Immunology (AREA)
• Medicinal Chemistry (AREA)
• Pharmacology & Pharmacy (AREA)
• Proteomics, Peptides & Aminoacids (AREA)
• Epidemiology (AREA)
• Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
• Magnetic Treatment Devices (AREA)
• Electrotherapy Devices (AREA)

Priority Applications (3)

Applications Claiming Priority (6)

Publications (1)

Family

ID=27365328

Family Applications (1)

Country Status (5)

Cited By (2)

Families Citing this family (72)

Citations (8)

Family Cites Families (34)

• 1997
  • 1997-12-04 US US08/984,885 patent/US5968527A/en not_active Expired - Lifetime
• 1998
  • 1998-02-26 EP EP98911390A patent/EP0975352A4/en not_active Withdrawn
  • 1998-02-26 WO PCT/US1998/003267 patent/WO1998037907A1/en not_active Ceased
  • 1998-02-26 JP JP53772298A patent/JP4135992B2/ja not_active Expired - Lifetime
  • 1998-02-26 AU AU65356/98A patent/AU6535698A/en not_active Abandoned
• 2007
  • 2007-10-26 JP JP2007279447A patent/JP4612667B2/ja not_active Expired - Lifetime
• 2010
  • 2010-07-15 JP JP2010160517A patent/JP2011041797A/ja active Pending

Patent Citations (10)

Non-Patent Citations (1)

Also Published As

Similar Documents

Legal Events